Laboratory of Immunology, NIAID, NIH, Bethesda, Maryland 20892-1892, USA.
J Clin Invest. 2011 Jan;121(1):16-9. doi: 10.1172/JCI45664. Epub 2010 Dec 22.
Advances in DNA sequencing technologies have increased attention on genetic variation in somatic tissues. Although long known to cause neoplastic diseases, somatic variation is now being investigated as a pathogenetic mechanism for other diseases. Somatic changes are genomic DNA variations that were not inherited but arise in tissues throughout life. In this issue of the JCI, Magerus-Chatinet et al. explore somatic changes in patients with autoimmune lymphoproliferative syndrome (ALPS), a congenital disease of defective apoptosis and autoimmunity that is usually associated with germline heterozygous mutations in the gene encoding the Fas death receptor. They explain why certain individuals have severe disease manifestations by documenting somatic alterations in the germline normal FAS allele in an unusual population of "double-negative" T cells found in ALPS. Thus, the oncological concept of somatic loss of heterozygosity leading to selected cell expansion also applies to autoimmune diseases.
DNA 测序技术的进步增加了人们对体细胞遗传变异的关注。虽然体细胞变异早已被认为是导致肿瘤性疾病的原因,但现在它也被作为其他疾病的发病机制进行研究。体细胞变化是指在整个生命过程中出现在组织中的非遗传的基因组 DNA 变异。在本期 JCI 中,Magerus-Chatinet 等人探索了自身免疫性淋巴增生综合征(ALPS)患者的体细胞变化。ALPS 是一种先天性凋亡和自身免疫缺陷疾病,通常与编码 Fas 死亡受体的基因的种系杂合突变有关。他们通过记录在 ALPS 中发现的“双阴性”T 细胞这一不寻常人群中,种系正常 FAS 等位基因的体细胞改变,解释了为什么某些个体具有严重的疾病表现。因此,肿瘤学中关于导致特定细胞扩增的体细胞杂合性丢失的概念也适用于自身免疫性疾病。